Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 5—May 2007
Letter

Expanded-spectrum β-Lactamase and Plasmid-mediated Quinolone Resistance

Laurent Poirel*Comments to Author , Laura Villa†, Alessia Bertini†, Johann D. Pitout‡, Patrice Nordmann*, and Alessandra Carattoli†
Author affiliations: *Hôpital de Bicêtre, K.-Bicêtre, France; †University of Calgary, Calgary, Alberta, Canada; ‡Istituto Superiore di Sanita, Rome, Italy;

Main Article

Table

Features of the VEB-1– or QnrA-positive isolates used in this study*

Strain†/Ref. Spp. of origin Country Year of isolation Plasmid size (kb) ESBL QnrA1 Replicon Associated non–β-lactam resistance markers
Escherichia coli TcE1 (5)
E. coli
Thailand
1999
160
VEB-1
+
A/C2
NAL, K, SSS, C, RA
E. coli TcE4 (5)
E. coli
Thailand
1999
150
VEB-1
+
A/C2
NAL, K, TM, SSS, C, RA
E. coli TcE5 (5)
E. coli
Thailand
1999
150
VEB-1
+
A/C2
NAL, K, TM, SSS, SXT
E. coli TcE7 (5)
E. coli
Thailand
1999
150
VEB-1
+
A/C2
NAL, K, TM, SSS, C, RA
E. coli TcE8 (5)
E. coli
Thailand
1999
150
VEB-1
+
A/C2
NAL, K, TM, SSS, TE
E. coli TcE16 (5)
E. coli
Thailand
1999
140
VEB-1
+
A/C2
NAL, K, TM, SSS, RA
E. coli TcE18 (5)
E. coli
Thailand
1999
180
VEB-1
+
A/C2
NAL, K, SSS, C, RA
E. coli Tc(pl) (5)
E. coli
Canada
2000
180
VEB-1
+
A/C2
NAL, K, SSS, C, RA
E. coli Tc(pQR1) (4)
E. coli
France
2003
180
VEB-1
+
A/C2
NAL, K, SSS, C, RA, SXT
E. coli Tc(GOC) (4)
Enterobacter cloacae
France
2003
190
VEB-1
+
A/C2, FIB
NAL, K, TM, SSS, C
Citrobacter freundii LUT (3)
C. freundii
Turkey
2004
ND
VEB-1
+
A/C2, FIB, K
NA
Providencia stuartii 15 (this study)
P. stuartii
Algeria
2004
ND
VEB-1

A/C2
NA
E. coli TcMAA (this study)
Proteus mirabilis
Algeria
2004
190
VEB-1

A/C2
K, TM, SSS, C, SXT
E. coli TcK147 (7)
Klebsiella pneumoniae
Australia
2002
160
SHV-12
+
HI2, A/C1, P
NAL, K, TM, C, TE, SXT
E. cloacae A1 (8)
E. cloacae
France
2004
75
SHV-12
+
HI2
NA
E. coli TcA2 (8)
Enterobacter aerogenes
France
2005
150
SHV-12
+
FII
NAL, K, TM, TE
E. coli TcA3 (8) K. pneumoniae France 2005 40 + I1, K NAL, K, TM, C, TE

*Ref., reference; ESBL, extended-spectrum β-lactamase; NAL, nalidixic acid; K, kanamycin; SSS, sulfonamides; C, chloramphenicol; RA, rifampin; TM, tobramycin; SXT, trimethoprim-sulfamethoxazole; TE, tetracycline; ND, not determinable; NA, not applicable.
†Tc indicates that this is a transconjugant or a transformant.

Main Article

References
  1. Martinez-Martinez  L, Pascual  A, Jacoby  GA. Quinolone resistance from a transferable plasmid. Lancet. 1998;351:7979. DOIPubMedGoogle Scholar
  2. Robicsek  A, Jacoby  GA, Hooper  DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006;6:62940. DOIPubMedGoogle Scholar
  3. Nordmann  P, Poirel  L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother. 2005;56:4639. DOIPubMedGoogle Scholar
  4. Poirel  L, Van De Loo  M, Mammeri  H, Nordmann  P. Association of plasmid-mediated quinolone resistance with extended-spectrum β-lactamase VEB-1. Antimicrob Agents Chemother. 2005;49:30914. DOIPubMedGoogle Scholar
  5. Girlich  D, Poirel  L, Leelaporn  A, Karim  A, Tribuddharat  C, Fennewald  M, Molecular epidemiology of the integron-located VEB-1 extended-spectrum β-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J Clin Microbiol. 2001;39:17582. DOIPubMedGoogle Scholar
  6. Poirel  L, Pitout  JD, Calvo  L, Rodriguez-Martinez  JM, Church  D, Nordmann  P. In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum β-lactamase. Antimicrob Agents Chemother. 2006;50:15257. DOIPubMedGoogle Scholar
  7. Rodriguez-Martinez  JM, Poirel  L, Pascual  A, Nordmann  P. Plasmid-mediated quinolone resistance in Australia. Microb Drug Resist. 2006;12:99102. DOIPubMedGoogle Scholar
  8. Poirel  L, Leviandier  C, Nordmann  P. Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae in a French University Hospital. Antimicrob Agents Chemother. 2006;50:39927. DOIPubMedGoogle Scholar
  9. Carattoli  A, Bertini  A, Villa  L, Falbo  V, Hopkins  KL, Threlfall  EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:21928. DOIPubMedGoogle Scholar
  10. Carattoli  A, Miriagou  V, Bertini  A, Loli  A, Colinon  C, Villa  L, Replicon typing of plasmids encoding resistance to newer β-lactams. Emerg Infect Dis. 2006;12:11458.PubMedGoogle Scholar

Main Article

Page created: June 23, 2010
Page updated: June 23, 2010
Page reviewed: June 23, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external